ParkinsonCanadaV1, PubMed, Curation, bibRecord, 000A38

Piecing together the puzzle of progression and mortality in Parkinson's disease.

Identifieur interne : 000A38 ( PubMed/Curation ); précédent : 000A37; suivant : 000A39

Piecing together the puzzle of progression and mortality in Parkinson's disease.

Auteurs : Connie Marras [Canada] ; David Oakes

Source :

British journal of clinical pharmacology [ 1365-2125 ] ; 2012.

RBID : pubmed:22554391

English descriptors

KwdEn :
- Antiparkinson Agents (therapeutic use), Cognition (drug effects), Cognition Disorders (drug therapy), Depression (drug therapy), Disability Evaluation, Humans, Motor Activity (drug effects), Parkinson Disease (drug therapy).
MESH :
- chemical , therapeutic use : Antiparkinson Agents.
- drug effects : Cognition, Motor Activity.
- drug therapy : Cognition Disorders, Depression, Parkinson Disease.
- Disability Evaluation, Humans.

DOI: 10.1111/j.1365-2125.2012.04315.x
PubMed: 22554391

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A38

Links to Exploration step

pubmed:22554391

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Piecing together the puzzle of progression and mortality in Parkinson's disease.</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
<affiliation wicri:level="1"><nlm:affiliation>Toronto Western Hospital Movement Disorders Centre, University of Toronto and the Edmond J. Safra Program in Parkinson's Research, Toronto, Ontario, Canada. connie.marras@utoronto.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Hospital Movement Disorders Centre, University of Toronto and the Edmond J. Safra Program in Parkinson's Research, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oakes, David" sort="Oakes, David" uniqKey="Oakes D" first="David" last="Oakes">David Oakes</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22554391</idno>
<idno type="pmid">22554391</idno>
<idno type="doi">10.1111/j.1365-2125.2012.04315.x</idno>
<idno type="wicri:Area/PubMed/Corpus">000A38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A38</idno>
<idno type="wicri:Area/PubMed/Curation">000A38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Piecing together the puzzle of progression and mortality in Parkinson's disease.</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
<affiliation wicri:level="1"><nlm:affiliation>Toronto Western Hospital Movement Disorders Centre, University of Toronto and the Edmond J. Safra Program in Parkinson's Research, Toronto, Ontario, Canada. connie.marras@utoronto.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Hospital Movement Disorders Centre, University of Toronto and the Edmond J. Safra Program in Parkinson's Research, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oakes, David" sort="Oakes, David" uniqKey="Oakes D" first="David" last="Oakes">David Oakes</name>
</author>
</analytic>
<series><title level="j">British journal of clinical pharmacology</title>
<idno type="eISSN">1365-2125</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term>
<term>Cognition (drug effects)</term>
<term>Cognition Disorders (drug therapy)</term>
<term>Depression (drug therapy)</term>
<term>Disability Evaluation</term>
<term>Humans</term>
<term>Motor Activity (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cognition</term>
<term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cognition Disorders</term>
<term>Depression</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disability Evaluation</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22554391</PMID>
<DateCreated><Year>2012</Year>
<Month>07</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2125</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>74</Volume>
<Issue>2</Issue>
<PubDate><Year>2012</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>British journal of clinical pharmacology</Title>
<ISOAbbreviation>Br J Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Piecing together the puzzle of progression and mortality in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>264-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2125.2012.04315.x</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marras</LastName>
<ForeName>Connie</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Toronto Western Hospital Movement Disorders Centre, University of Toronto and the Edmond J. Safra Program in Parkinson's Research, Toronto, Ontario, Canada. connie.marras@utoronto.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Oakes</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Br J Clin Pharmacol</MedlineTA>
<NlmUniqueID>7503323</NlmUniqueID>
<ISSNLinking>0306-5251</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2000 Dec 26;55(12):1770-1</RefSource>
<PMID Version="1">11134369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2000 Dec 26;55(12):1785-9</RefSource>
<PMID Version="1">11134373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2002 Nov;59(11):1724-8</RefSource>
<PMID Version="1">12433259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 1995 Dec 16;311(7020):1602-7</RefSource>
<PMID Version="1">8555803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):228-34</RefSource>
<PMID Version="1">9285463</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 1998 Jul 25;317(7153):252-4</RefSource>
<PMID Version="1">9677215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 1998 Sep;51(3):825-30</RefSource>
<PMID Version="1">9748034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Clin Pharmacol. 2012 Aug;74(2):284-95</RefSource>
<PMID Version="1">22300470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Clin Pharmacol. 2012 Aug;74(2):267-83</RefSource>
<PMID Version="1">22283961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Oct 15;22(13):1839-51; quiz 1988</RefSource>
<PMID Version="1">17595026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Br J Clin Pharmacol. 2013 May;75(5):1372</RefSource>
<PMID Version="1">22989073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Br J Clin Pharmacol. 2013 May;75(5):1370-1</RefSource>
<PMID Version="1">22989096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn"><RefSource>Br J Clin Pharmacol. 2012 Aug;74(2):267-83</RefSource>
<PMID Version="1">22283961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn"><RefSource>Br J Clin Pharmacol. 2012 Aug;74(2):284-95</RefSource>
<PMID Version="1">22300470</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004185" MajorTopicYN="Y">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3630746</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22554391</ArticleId>
<ArticleId IdType="doi">10.1111/j.1365-2125.2012.04315.x</ArticleId>
<ArticleId IdType="pmc">PMC3630746</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A38 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22554391
   |texte=   Piecing together the puzzle of progression and mortality in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22554391" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Piecing together the puzzle of progression and mortality in Parkinson's disease.

Piecing together the puzzle of progression and mortality in Parkinson's disease.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki